Thermocore Medical Systems
This article was originally published in The Gray Sheet
Executive Summary
Venture capital arm of the Bank of Cyprus and a group of private investors provides "several" million dollars in funding for preclinical development of a thermography catheter to identify previously undetectable and high-risk areas of diseased coronary arteries. Working in cooperation with consulting firm Arthur D. Little, Thermocore will incorporate an array of sensors to map the interior of arteries on the basis of temperature variations. "Clinical data generated by an early version of such a device showed greater thermal variations in patients with unstable angina and acute myocardial infarction than in patients with normal coronary arteries," Thermocore explains in a release. The device, which would serve as a complement to angiograms, is expected to enter European trials within six to eight months and begin U.S. trials in the second half of 2002